Skip to content

FP7

MITCARE

Mitochondrial Medicine: developing treatments of OXPHOS-defects in recombinant mammalian models.

Programme
Seventh Framework Programme
Started
Ends
Duration
66 months
Total cost
EUR 2,500,000
EU contribution
EUR 2,500,000
Participants
3 from 2 countries
Topic
FP7_ERC-AG-LS4
Grant agreement
322424

Coordinated by The Chancellor Masters and Scholars of the University of Cambridge (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
The Chancellor Masters and Scholars of the University of CambridgeGBUnited KingdomCoordinatorEUR 2,004,284known name (0.95)
Avantea SRLITItalyParticipantEUR 401,000PIC (1.00)
Fondazione Irccs Istituto Neurologico Carlo BestaITItalyParticipantEUR 94,716known name (0.95)

Changes of the consortium

First seen on with 3 participants from 2 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.